{"transactions":[{"id":776814,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-05-15T20:28:56.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":33222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU was granted on May 14, 2026, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU was granted on May 14, 2026, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU was granted on May 14, 2026, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."}],"balance_after":33222,"derivative":{"underlying":"Common Stock","underlying_shares":33222},"source":{"system":"sec-edgar","filing":"0001256230-26-000002","document":"form4-05152026_080552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623026000002/form4-05152026_080552.xml","form_type":"4"}},{"id":776813,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-05-15T20:28:56.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":false,"shares":15757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2025, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 14, 2026, the day of the issuer's annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2025, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 14, 2026, the day of the issuer's annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2025, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 14, 2026, the day of the issuer's annual meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15757},"source":{"system":"sec-edgar","filing":"0001256230-26-000002","document":"form4-05152026_080552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623026000002/form4-05152026_080552.xml","form_type":"4"}},{"id":776812,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2026-05-15T20:28:56.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":true,"shares":15757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2025, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 14, 2026, the day of the issuer's annual meeting."}],"balance_after":50708,"source":{"system":"sec-edgar","filing":"0001256230-26-000002","document":"form4-05152026_080552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623026000002/form4-05152026_080552.xml","form_type":"4"}},{"id":984917,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-12-02T00:02:51.000Z","date":"2025-11-26","kind":"exercise","planned":true,"acquired":true,"shares":14000,"price":10.15,"value":142100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Share Option was fully vested and exercisable (having vested as to 1/12th of the shares subject to the option upon completion of each continuous month of service following the original grant date and any remaining unvested shares vesting on the date of the next annual meeting of the company's shareholders provided continuous service through such date)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects solely exercisable, vested Share Options following reported transaction."}],"balance_after":81749,"derivative":{"exercise_price":10.15,"expiration_date":"2032-04-25","underlying":"Ordinary Shares","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001256230-25-000009","document":"form4-12022025_121248.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623025000009/form4-12022025_121248.xml","form_type":"4"}},{"id":984916,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-02T00:02:51.000Z","date":"2025-11-26","kind":"sale","planned":true,"acquired":false,"shares":15501,"price":20,"value":310020.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024."}],"balance_after":44703,"source":{"system":"sec-edgar","filing":"0001256230-25-000009","document":"form4-12022025_121248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623025000009/form4-12022025_121248.xml","form_type":"4"}},{"id":984915,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-02T00:02:51.000Z","date":"2025-11-26","kind":"sale","planned":true,"acquired":false,"shares":14000,"price":20,"value":280000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person exercised stock options to acquire 14,000 Ordinary Shares and sold all such shares on the same day in a broker-assisted transaction. No shares were withheld for taxes. The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024."}],"balance_after":60204,"source":{"system":"sec-edgar","filing":"0001256230-25-000009","document":"form4-12022025_121248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623025000009/form4-12022025_121248.xml","form_type":"4"}},{"id":998751,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-11-14T11:00:16.000Z","date":"2025-11-11","kind":"exercise","planned":false,"acquired":true,"shares":14000,"price":10.15,"value":142100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable (having vested as to 1/12th of the shares subject to the option upon completion of each continuous month of service following the original grant date and any remaining unvested shares vesting on the date of the next annual meeting of the company's shareholders provided continuous service through such date)."}],"balance_after":107878,"derivative":{"exercise_price":10.15,"expiration_date":"2032-04-25","underlying":"Ordinary Shares","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001256230-25-000007","document":"form4a-11142025_061102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623025000007/form4a-11142025_061102.xml","form_type":"4/A","original_submission_date":"2025-11-13"}},{"id":998750,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-14T11:00:16.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":14000,"price":18.5,"value":259000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person exercised stock options to acquire 14,000 Ordinary Shares and sold all such shares on the same day in a broker-assisted transaction. No shares were withheld for taxes. The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024."}],"balance_after":60204,"source":{"system":"sec-edgar","filing":"0001256230-25-000007","document":"form4a-11142025_061102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623025000007/form4a-11142025_061102.xml","form_type":"4/A","original_submission_date":"2025-11-13"}},{"id":998749,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-14T11:00:16.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":15500,"price":17,"value":263500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024."}],"balance_after":60204,"source":{"system":"sec-edgar","filing":"0001256230-25-000007","document":"form4a-11142025_061102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623025000007/form4a-11142025_061102.xml","form_type":"4/A","original_submission_date":"2025-11-13"}},{"id":998748,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-14T11:00:16.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":15500,"price":18.5,"value":286750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024."}],"balance_after":75704,"source":{"system":"sec-edgar","filing":"0001256230-25-000007","document":"form4a-11142025_061102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623025000007/form4a-11142025_061102.xml","form_type":"4/A","original_submission_date":"2025-11-13"}},{"id":999991,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-11-14T02:00:16.000Z","date":"2025-11-11","kind":"exercise","planned":false,"acquired":true,"shares":14000,"price":10.15,"value":142100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable (having vested as to 1/12th of the shares subject to the option upon completion of each continuous month of service following the original grant date and any remaining unvested shares vesting on the date of the next annual meeting of the company's shareholders provided continuous service through such date)."}],"balance_after":107878,"derivative":{"exercise_price":10.15,"expiration_date":"2032-04-25","underlying":"Ordinary Shares","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001256230-25-000006","document":"form4-11142025_021112.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623025000006/form4-11142025_021112.xml","form_type":"4"}},{"id":999990,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-14T02:00:16.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":14000,"price":18.5,"value":259000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person exercised stock options to acquire 14,000 Ordinary Shares and sold all such shares on the same day in a broker-assisted transaction. No shares were withheld for taxes.  The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024."}],"balance_after":46204,"source":{"system":"sec-edgar","filing":"0001256230-25-000006","document":"form4-11142025_021112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623025000006/form4-11142025_021112.xml","form_type":"4"}},{"id":999989,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-14T02:00:16.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":15500,"price":17,"value":263500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024."}],"balance_after":46204,"source":{"system":"sec-edgar","filing":"0001256230-25-000006","document":"form4-11142025_021112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623025000006/form4-11142025_021112.xml","form_type":"4"}},{"id":999988,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-14T02:00:16.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":29500,"price":18.5,"value":545750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024."}],"balance_after":61704,"source":{"system":"sec-edgar","filing":"0001256230-25-000006","document":"form4-11142025_021112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000125623025000006/form4-11142025_021112.xml","form_type":"4"}},{"id":1136834,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2025-05-22T20:58:35.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":15757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU was granted on May 21, 2025, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU was granted on May 21, 2025, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU was granted on May 21, 2025, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."}],"balance_after":15757,"derivative":{"underlying":"Common Stock","underlying_shares":15757},"source":{"system":"sec-edgar","filing":"0001415889-25-014182","document":"form4-05222025_080532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588925014182/form4-05222025_080532.xml","form_type":"4"}},{"id":1136833,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Restricted Stock Units","published_at":"2025-05-22T20:58:35.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":false,"shares":11928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2024, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2025, the day of the issuer's annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2024, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2025, the day of the issuer's annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2024, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2025, the day of the issuer's annual meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11928},"source":{"system":"sec-edgar","filing":"0001415889-25-014182","document":"form4-05222025_080532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588925014182/form4-05222025_080532.xml","form_type":"4"}},{"id":1136832,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Common Stock","published_at":"2025-05-22T20:58:35.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":true,"shares":11928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2024, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2025, the day of the issuer's annual meeting."}],"balance_after":34951,"source":{"system":"sec-edgar","filing":"0001415889-25-014182","document":"form4-05222025_080532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588925014182/form4-05222025_080532.xml","form_type":"4"}},{"id":1138823,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-21T23:02:54.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":24258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":24258,"derivative":{"exercise_price":9.39,"expiration_date":"2035-05-18","underlying":"Ordinary Shares","underlying_shares":24258},"source":{"system":"sec-edgar","filing":"0001415889-25-014000","document":"form4-05212025_110551.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588925014000/form4-05212025_110551.xml","form_type":"4"}},{"id":1138822,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-21T23:02:54.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":10649,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91204,"source":{"system":"sec-edgar","filing":"0001415889-25-014000","document":"form4-05212025_110551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588925014000/form4-05212025_110551.xml","form_type":"4"}},{"id":1503405,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-23T20:17:54.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":11928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU was granted on May 21, 2024, under the Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU was granted on May 21, 2024, under the Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU was granted on May 21, 2024, under the Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."}],"balance_after":11928,"derivative":{"underlying":"Common Stock","underlying_shares":11928},"source":{"system":"sec-edgar","filing":"0001415889-24-014248","document":"form4-05232024_080549.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588924014248/form4-05232024_080549.xml","form_type":"4"}},{"id":1503404,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-23T20:17:54.000Z","date":"2024-05-21","kind":"exercise","planned":false,"acquired":false,"shares":8663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 23, 2023, under Certara, Inc.'s 2020 Incentive Plan (\"Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2024, the day of the issuer's annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 23, 2023, under Certara, Inc.'s 2020 Incentive Plan (\"Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2024, the day of the issuer's annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 23, 2023, under Certara, Inc.'s 2020 Incentive Plan (\"Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2024, the day of the issuer's annual meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8663},"source":{"system":"sec-edgar","filing":"0001415889-24-014248","document":"form4-05232024_080549.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588924014248/form4-05232024_080549.xml","form_type":"4"}},{"id":1503403,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T20:17:54.000Z","date":"2024-05-21","kind":"exercise","planned":false,"acquired":true,"shares":8663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 23, 2023, under Certara, Inc.'s 2020 Incentive Plan (\"Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2024, the day of the issuer's annual meeting."}],"balance_after":23023,"source":{"system":"sec-edgar","filing":"0001415889-24-014248","document":"form4-05232024_080549.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588924014248/form4-05232024_080549.xml","form_type":"4"}},{"id":1520435,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-05-10T22:02:59.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":23576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":23576,"derivative":{"exercise_price":9.49,"expiration_date":"2034-05-07","underlying":"Ordinary Shares","underlying_shares":23576},"source":{"system":"sec-edgar","filing":"0001415889-24-012908","document":"form4-05102024_100548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588924012908/form4-05102024_100548.xml","form_type":"4"}},{"id":1520434,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-05-10T22:02:59.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":10537,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80555,"source":{"system":"sec-edgar","filing":"0001415889-24-012908","document":"form4-05102024_100548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588924012908/form4-05102024_100548.xml","form_type":"4"}},{"id":1798494,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-23T20:38:56.000Z","date":"2023-08-22","kind":"purchase","planned":false,"acquired":true,"shares":4807,"price":15.8,"value":75950.6,"ownership":{"direct":true},"balance_after":14360,"source":{"system":"sec-edgar","filing":"0001415889-23-012566","document":"form4-08232023_080847.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588923012566/form4-08232023_080847.xml","form_type":"4"}},{"id":1798493,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-23T20:38:56.000Z","date":"2023-08-21","kind":"purchase","planned":false,"acquired":true,"shares":193,"price":16.1,"value":3107.3,"ownership":{"direct":true},"balance_after":9553,"source":{"system":"sec-edgar","filing":"0001415889-23-012566","document":"form4-08232023_080847.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588923012566/form4-08232023_080847.xml","form_type":"4"}},{"id":1877789,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-25T12:50:46.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":8663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents RSUs granted on May 23, 2023, under the 2020 Incentive Plan that entitles the reporting person to receive one share of the issuer's common stock per RSU.  The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual shareholder meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents RSUs granted on May 23, 2023, under the 2020 Incentive Plan that entitles the reporting person to receive one share of the issuer's common stock per RSU.  The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual shareholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents RSUs granted on May 23, 2023, under the 2020 Incentive Plan that entitles the reporting person to receive one share of the issuer's common stock per RSU.  The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual shareholder meeting."}],"balance_after":8663,"derivative":{"underlying":"Common Stock","underlying_shares":8663},"source":{"system":"sec-edgar","filing":"0001415889-23-008754","document":"form4-05252023_120542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588923008754/form4-05252023_120542.xml","form_type":"4"}},{"id":1877788,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-25T12:50:46.000Z","date":"2023-05-23","kind":"exercise","planned":false,"acquired":false,"shares":9360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on July 13, 2022, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") that entitles the reporting person to receive one share of the issuer's common stock per RSU.  The RSUs vested and were converted into common shares on the day of the annual meeting of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on July 13, 2022, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") that entitles the reporting person to receive one share of the issuer's common stock per RSU.  The RSUs vested and were converted into common shares on the day of the annual meeting of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on July 13, 2022, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") that entitles the reporting person to receive one share of the issuer's common stock per RSU.  The RSUs vested and were converted into common shares on the day of the annual meeting of the issuer."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9360},"source":{"system":"sec-edgar","filing":"0001415889-23-008754","document":"form4-05252023_120542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588923008754/form4-05252023_120542.xml","form_type":"4"}},{"id":1877787,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T12:50:46.000Z","date":"2023-05-23","kind":"exercise","planned":false,"acquired":true,"shares":9360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on July 13, 2022, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") that entitles the reporting person to receive one share of the issuer's common stock per RSU.  The RSUs vested and were converted into common shares on the day of the annual meeting of the issuer."}],"balance_after":9360,"source":{"system":"sec-edgar","filing":"0001415889-23-008754","document":"form4-05252023_120542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588923008754/form4-05252023_120542.xml","form_type":"4"}},{"id":1904174,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2023-05-04T22:36:08.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":22044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":22044,"derivative":{"exercise_price":10.95,"expiration_date":"2033-05-01","underlying":"Ordinary Shares","underlying_shares":22044},"source":{"system":"sec-edgar","filing":"0001415889-23-007374","document":"form4-05042023_100502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588923007374/form4-05042023_100502.xml","form_type":"4"}},{"id":1904173,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-05-04T22:36:08.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":9132,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70018,"source":{"system":"sec-edgar","filing":"0001415889-23-007374","document":"form4-05042023_100502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588923007374/form4-05042023_100502.xml","form_type":"4"}},{"id":2206842,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-07-15T20:35:18.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":9360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 9,360 RSUs granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual shareholder meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual shareholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual shareholder meeting."}],"balance_after":9360,"derivative":{"underlying":"Common Stock","underlying_shares":9360},"source":{"system":"sec-edgar","filing":"0001415889-22-007690","document":"form4-07152022_010709.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588922007690/form4-07152022_010709.xml","form_type":"4"}},{"id":2288681,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2022-04-29T00:54:58.000Z","date":"2022-04-26","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":28000,"derivative":{"exercise_price":10.15,"expiration_date":"2032-04-25","underlying":"Ordinary Shares","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001415889-22-004328","document":"form4-04282022_050458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588922004328/form4-04282022_050458.xml","form_type":"4"}},{"id":2288680,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-04-29T00:54:58.000Z","date":"2022-04-26","kind":"grant","acquired":true,"shares":9852,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60886,"source":{"system":"sec-edgar","filing":"0001415889-22-004328","document":"form4-04282022_050458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000141588922004328/form4-04282022_050458.xml","form_type":"4"}},{"id":2735642,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2021-04-29T22:12:31.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":20.35,"expiration_date":"2031-04-26","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-21-004697","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000117911021004697/edgar.xml","form_type":"4"}},{"id":2735641,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-04-29T22:12:31.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":9828,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":51034,"source":{"system":"sec-edgar","filing":"0001179110-21-004697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000117911021004697/edgar.xml","form_type":"4"}},{"id":3166344,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2020-04-30T22:52:06.000Z","date":"2020-04-28","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":30.14,"expiration_date":"2030-04-27","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-20-005295","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000117911020005295/edgar.xml","form_type":"4"}},{"id":3166343,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-04-30T22:52:06.000Z","date":"2020-04-28","kind":"grant","acquired":true,"shares":6635,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41206,"source":{"system":"sec-edgar","filing":"0001179110-20-005295","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000117911020005295/edgar.xml","form_type":"4"}},{"id":3542083,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2019-05-02T22:14:39.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":23.85,"expiration_date":"2029-04-29","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-19-005453","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000117911019005453/edgar.xml","form_type":"4"}},{"id":3542082,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-02T22:14:39.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":8385,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34571,"source":{"system":"sec-edgar","filing":"0001179110-19-005453","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000117911019005453/edgar.xml","form_type":"4"}},{"id":3918152,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2018-05-25T17:14:33.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":1685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual director restricted stock award pursuant to 2016 Management Incentive Plan. Shares shall vest fully on the date of the 2019 Annual Meeting of Shareholders."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":9645,"source":{"system":"sec-edgar","filing":"0001209191-18-033582","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919118033582/doc4.xml","form_type":"4"}},{"id":3947067,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2018-05-03T22:11:52.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":24.43,"expiration_date":"2028-04-30","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-18-006188","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000117911018006188/edgar.xml","form_type":"4"}},{"id":3947066,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-03T22:11:52.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":8186,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26186,"source":{"system":"sec-edgar","filing":"0001179110-18-006188","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000117911018006188/edgar.xml","form_type":"4"}},{"id":4304218,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2017-05-26T12:58:08.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":2137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares shall vest fully on the date of the 2018 Annual Meeting of Shareholders."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":10097,"source":{"system":"sec-edgar","filing":"0001209191-17-035735","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919117035735/doc4.xml","form_type":"4"}},{"id":4313339,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-05-18T22:02:07.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001179110-17-007537","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256230/000117911017007537/edgar.xml","form_type":"4"}},{"id":4423699,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2017-02-27T10:38:11.000Z","date":"2017-02-23","kind":"sale","acquired":false,"shares":4867,"price":80,"value":389360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effectuated pursuant to a Rule 10b-5-1 Plan."}],"balance_after":7960,"source":{"system":"sec-edgar","filing":"0001209191-17-014580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919117014580/doc4.xml","form_type":"4"}},{"id":4526664,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":46842,"kind":"person","name":"BROSHY ERAN","position":1,"cik":"0001256230","reported_name":"BROSHY ERAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2016-12-12T16:05:47.000Z","date":"2016-12-08","kind":"sale","acquired":false,"shares":2433,"price":75,"value":182475.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effectuated pursuant to a Rule 10b-5-1 Plan."}],"balance_after":12827,"source":{"system":"sec-edgar","filing":"0001209191-16-154686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919116154686/doc4.xml","form_type":"4"}}]}